Clinical Trial Results:
Estudio Fase III, multicéntrico, aleatorizado, doble ciego, controlado con placebo, de ASA404 en combinación con docetaxel, como tratamiento de segunda línea para pacientes con cáncer de pulmón de células no pequeñas (NSCLC) localmente avanzado o metastásico (estadio IIIb/IV)
Summary
|
|
EudraCT number |
2008-002309-38 |
Trial protocol |
ES BE DE IT GB HU PL NL |
Global completion date |
20 Dec 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
14 Sep 2016
|
First version publication date |
14 Sep 2016
|
Other versions |
|
Summary report(s) |
CASA404A2302.CTR.17Aug2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.